Regitz-Zagrosek, V <br/><br/>
Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Jul 1995 
 - 66-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Standard No.: </label>10.1097/00005344-199507000-00011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adrenal Cortex--drug effects<br/>Adrenal Medulla--drug effects<br/>Angiotensin II--administration & dosage<br/>Angiotensin Receptor Antagonists<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Animals<br/>Antihypertensive Agents--metabolism<br/>Biphenyl Compounds--metabolism<br/>Cyclosporine--administration & dosage<br/>Down-Regulation<br/>Drug Interactions<br/>Imidazoles--metabolism<br/>Kidney--drug effects<br/>Lisinopril--pharmacology<br/>Liver--drug effects<br/>Losartan<br/>Male<br/>Pyridines--metabolism<br/>Quinolines--pharmacology<br/>Radioligand Assay<br/>Rats<br/>Rats, Wistar<br/>Receptors, Angiotensin--drug effects<br/>Tetrazoles--metabolism<br/>Up-Regulation